Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
22 August 2022 |
Main ID: |
NCT04595045 |
Date of registration:
|
09/09/2020 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple Sclerosis
|
Scientific title:
|
Effectiveness of Botulinum Toxin Type A Infiltrations in the Gait and Quality of Life in Adults With Spastic Lower Limb Paresis Secondary to Multiple Sclerosis |
Date of first enrolment:
|
January 24, 2019 |
Target sample size:
|
84 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT04595045 |
Study type:
|
Interventional |
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
Phase:
|
Phase 3
|
|
Countries of recruitment
|
Spain
| | | | | | | |
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Source(s) of Monetary Support
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|